Figure 4.
At least one in 200 (0.5%) patients has all adult-onset ESRD due to nephronophthisis, but the overall prevalence is likely higher. The late presentation of nephronophthisis might be due to genetic modifier effects. Accurately diagnosing a monogenic disease such as nephronophthisis can have wide-ranging clinical implications.